Price movement over the last 24 hours
Acset Indonusa Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Acset Indonusa Tbk trades at Rp76 (market cap 1.36T, 45.9K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.74M 24h volume). The key difference: Acset Indonusa Tbk is far larger — about 4.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (1.74M versus 45.9K). Which is the better fit depends on your goals.
| ACST | DGNS | |
|---|---|---|
Market Cap | 1.36T | 319B |
Volume | 45.9K | 1.74M |
Lot | 459 | 17.44K |
Turnover | 3.52M | 400.92M |
Average Price | 76.75 | 229.87 |
Value | 3.52M | 400.92M |
Indicative Equilibrium Price | 76 | 232 |
Indicative Equilibrium Volume | 36 | 212 |
Trailing returns across standard periods
Latest headlines on both assets
PT Acset Indonusa Tbk (the Company) was establised based on Notarial Deed No.2 dated January 10, 1995 of Ny. Liliana Arif Gondoutomo, S.H., Notary in Bekasi.
Read more on ACST →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →